Drug Discovery 인포매틱스 시장 규모, 점유율, 성장 분석, 기능별, 용도별, 솔루션별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Drug Discovery Informatics Market Size, Share, and Growth Analysis, By Function (Sequencing and Target Data Analysis, Docking), By Application (Drug Discovery, Drug Development), By Solution, By End User, By Region - Industry Forecast 2025-2032
Drug Discovery 인포매틱스 세계 시장 규모는 2023년 32억 9,000만 달러로 평가되었습니다. 2024년 36억 6,000만 달러에서 2032년에는 86억 2,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 11.3%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 Drug Discovery 인포매틱스 시장은 생명공학 및 제약사들의 연구 투자 강화와 희귀질환 치료 및 희귀질환 치료제 개발에 대한 수요 증가로 인해 크게 성장하고 있습니다. 이러한 연구비 증가는 신약 개발에 있어 데이터 관리의 중요한 역할을 강조하고 있으며, 의약품 및 화합물에 대한 광범위한 데이터베이스는 의약품 연구에 필수적입니다. 현대의 인포매틱스는 고성능 컴퓨팅과 온라인 서비스 향상에 힘입어 효과적인 데이터 처리, 관리 및 분석을 위해 첨단 소프트웨어를 채택하고 있습니다. 또한, 의약품 개발에 대한 관심 증가, 새로운 치료제에 대한 수요 증가, 인실리코 분석의 보급이 시장 확대를 더욱 촉진하고 있습니다. 그러나 인포매틱스 도구와 관련된 높은 비용이 성장의 걸림돌이 될 수 있는 반면, 개발도상국의 신흥 바이오테크놀러지 분야에는 유리한 기회가 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 규제 분석
- 기술 분석
- 특허 분석
Drug Discovery 인포매틱스 시장 규모 : 기능별
- 시장 개요
- 시퀀싱 및 타겟 데이터 분석
- 도킹
- 분자 모델링
- 라이브러리 및 데이터베이스 준비
- 기타 기능
Drug Discovery 인포매틱스 시장 규모 : 용도별
- 시장 개요
- Drug Discovery
- 의약품 개발
Drug Discovery 인포매틱스 시장 규모 : 솔루션별
Drug Discovery 인포매틱스 시장 규모 : 최종사용자별
- 시장 개요
- 제약회사
- 바이오테크놀러지 기업
- 조사 업무 수탁 기관(CRO)
- 기타 최종사용자
Drug Discovery 인포매틱스 시장 규모
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 전년대비 매출 비교(2022-2024년)
주요 기업 개요
- IBM(United States)
- Infosys Limited(India)
- Thermo Fisher Scientific(United States)
- PerkinElmer Inc.(United States)
- Schrodinger, Inc.(United States)
- Charles River Laboratories International, Inc.(United States)
- Certara, Inc.(United States)
- Accenture plc(Ireland)
- Agilent Technologies, Inc.(United States)
- Illumina, Inc.(United States)
- Dassault Systemes SE(France)
- Collaborative Drug Discovery, Inc.(United States)
- Eurofins DiscoverX Products(United States)
- Jubilant Biosys Limited(India)
- Selvita S.A.(Poland)
- Novo Informatics Pvt. Ltd.(India)
- ChemAxon Ltd.(Hungary)
- Albany Molecular Research Inc.(United States)
- Boehringer Ingelheim GmbH(Germany)
- Oracle Corporation(United States)
결론과 제안
LSH
Global Drug Discovery Informatics Market size was valued at USD 3.29 billion in 2023 and is poised to grow from USD 3.66 billion in 2024 to USD 8.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).
The global drug discovery informatics market is witnessing significant growth driven by rising demand for rare illness treatments and orphan drug development, alongside enhanced research investment by biotechnology and pharmaceutical companies. This surge in research expenditure highlights the vital role of data management in drug discovery, where extensive databases of drugs and compounds are essential for pharmaceutical research. Modern informatics employs advanced software for effective data processing, management, and analysis, supported by improvements in high-performance computing and online services. Additionally, the growing focus on drug development, increasing need for new therapeutics, and widespread adoption of in silico modeling technology further propel market expansion. However, the high costs associated with informatics tools may hinder growth, while emerging biotech sectors in developing nations present lucrative opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Drug Discovery Informatics Market Segments Analysis
Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Drug Discovery Informatics Market
The global drug discovery informatics market is significantly propelled by the swift developments in technology, especially in artificial intelligence (AI) and machine learning (ML). These innovations enhance data analysis capabilities, enabling researchers to process vast amounts of information swiftly and accurately. This increased efficiency not only streamlines the identification of molecular candidates for drug development but also expedites the overall drug discovery process. By harnessing powerful algorithms and predictive analytics, AI and ML are revolutionizing how pharmaceutical companies approach drug development, thereby driving the growth of the drug discovery informatics market on a global scale.
Restraints in the Global Drug Discovery Informatics Market
The Global Drug Discovery Informatics market faces significant obstacles due to concerns surrounding data protection and the necessity to adhere to legal regulations. Compliance with privacy laws, such as the General Data Protection Regulation (GDPR), complicates the management and sharing of critical information. As a result, these regulatory challenges hinder research efforts and create barriers that limit the adoption of advanced informatics technologies by companies. Consequently, this situation stifles innovation and growth within the market, making it increasingly difficult for organizations to leverage new insights and capabilities essential for advancing drug discovery processes on a global scale.
Market Trends of the Global Drug Discovery Informatics Market
The Global Drug Discovery Informatics market is witnessing a significant trend towards the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. This shift is revolutionizing the industry by enhancing data analysis capabilities, expediting the identification of potential drug candidates, and leveraging predictive modeling to streamline the drug discovery process. As a result, pharmaceutical companies and research institutions are experiencing heightened creativity and operational efficiency, driving the demand for advanced informatics solutions. This trend indicates a transformative approach to drug discovery, promising more innovative therapies and faster time-to-market, thus positioning AI and ML as pivotal elements in the future of pharmacological research.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Analysis
- Technology Analysis
- Patent Analysis
Global Drug Discovery Informatics Market Size by Function & CAGR (2025-2032)
- Market Overview
- Sequencing and Target Data Analysis
- Docking
- Molecular Modelling
- Library & Database Preparation
- Other functions
Global Drug Discovery Informatics Market Size by Application & CAGR (2025-2032)
- Market Overview
- Drug Discovery
- Drug Development
- Preclinical Testing
- Clinical Trials
Global Drug Discovery Informatics Market Size by Solution & CAGR (2025-2032)
- Market Overview
- Software
- Services
Global Drug Discovery Informatics Market Size by End User & CAGR (2025-2032)
- Market Overview
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organization (CROs)
- Other End Users
Global Drug Discovery Informatics Market Size & CAGR (2025-2032)
- North America (Function, Application, Solution, End User)
- Europe (Function, Application, Solution, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Function, Application, Solution, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Function, Application, Solution, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Function, Application, Solution, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- IBM (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Infosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Schrodinger, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Certara, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Accenture plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dassault Systemes SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Collaborative Drug Discovery, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins DiscoverX Products (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jubilant Biosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Selvita S.A. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Informatics Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ChemAxon Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Albany Molecular Research Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oracle Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
